Article Details
Retrieved on: 2022-11-29 16:59:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Merck KGaA, Darmstadt, Germany and Pfizer. The collaboration involves a new phase 1 study – INSIGHT-005 – in patients with urothelial cancer.
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here